Barbara Castella

1.2k total citations
28 papers, 947 citations indexed

About

Barbara Castella is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Barbara Castella has authored 28 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 9 papers in Hematology and 8 papers in Oncology. Recurrent topics in Barbara Castella's work include Immune Cell Function and Interaction (14 papers), Multiple Myeloma Research and Treatments (9 papers) and T-cell and B-cell Immunology (8 papers). Barbara Castella is often cited by papers focused on Immune Cell Function and Interaction (14 papers), Multiple Myeloma Research and Treatments (9 papers) and T-cell and B-cell Immunology (8 papers). Barbara Castella collaborates with scholars based in Italy, Belarus and United States. Barbara Castella's co-authors include Massimo Massaia, Chiara Riganti, Myriam Foglietta, Mario Boccadoro, Marta Coscia, Francesca Pantaleoni, Joanna Kopecka, Candida Vitale, Silvia Peola and Elena Gazzano and has published in prestigious journals such as Nature Communications, Blood and The Journal of Immunology.

In The Last Decade

Barbara Castella

28 papers receiving 930 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Castella Italy 17 490 405 265 162 159 28 947
Wenzhi Tian China 16 695 1.4× 431 1.1× 292 1.1× 34 0.2× 73 0.5× 53 1.1k
Grégory Ehx Belgium 16 294 0.6× 213 0.5× 270 1.0× 262 1.6× 42 0.3× 39 696
Ninib Baryawno Sweden 16 213 0.4× 292 0.7× 586 2.2× 61 0.4× 259 1.6× 35 1.1k
James J. Ignatz-Hoover United States 12 251 0.5× 273 0.7× 379 1.4× 124 0.8× 81 0.5× 25 749
Joel Crespo United States 7 863 1.8× 674 1.7× 396 1.5× 34 0.2× 183 1.2× 8 1.4k
Hind Medyouf Germany 13 220 0.4× 298 0.7× 526 2.0× 247 1.5× 157 1.0× 23 976
Leticía Huergo-Zapico Spain 14 540 1.1× 349 0.9× 145 0.5× 85 0.5× 55 0.3× 19 775
Bruno A. Cardoso Portugal 14 234 0.5× 230 0.6× 434 1.6× 250 1.5× 91 0.6× 25 858
W Zhang United States 13 225 0.5× 437 1.1× 550 2.1× 144 0.9× 259 1.6× 19 1.0k

Countries citing papers authored by Barbara Castella

Since Specialization
Citations

This map shows the geographic impact of Barbara Castella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Castella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Castella more than expected).

Fields of papers citing papers by Barbara Castella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Castella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Castella. The network helps show where Barbara Castella may publish in the future.

Co-authorship network of co-authors of Barbara Castella

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Castella. A scholar is included among the top collaborators of Barbara Castella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Castella. Barbara Castella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maione, Federica, Daniele Oddo, Chiara Falcomatà, et al.. (2024). Preclinical efficacy of carfilzomib in BRAF ‐mutant colorectal cancer models. Molecular Oncology. 18(6). 1552–1570. 4 indexed citations
2.
Giannotta, Claudia, Barbara Castella, Ilaria Avonto, et al.. (2022). Immune dysfunctions affecting bone marrow Vγ9Vδ2 T cells in multiple myeloma: Role of immune checkpoints and disease status. Frontiers in Immunology. 13. 1073227–1073227. 4 indexed citations
3.
Kopecka, Joanna, Elena Gazzano, Barbara Castella, et al.. (2019). Mitochondrial metabolism: Inducer or therapeutic target in tumor immune-resistance?. Seminars in Cell and Developmental Biology. 98. 80–89. 14 indexed citations
4.
Morandi, Fabio, Alberto L. Horenstein, Valeria Quarona, et al.. (2018). Ectonucleotidase Expression on Human Amnion Epithelial Cells: Adenosinergic Pathways and Dichotomic Effects on Immune Effector Cell Populations. The Journal of Immunology. 202(3). 724–735. 12 indexed citations
5.
Morandi, Fabio, Danilo Marimpietri, Alberto L. Horenstein, et al.. (2018). Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD+. OncoImmunology. 7(8). e1458809–e1458809. 68 indexed citations
6.
Riganti, Chiara, Barbara Castella, & Massimo Massaia. (2018). ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells. Frontiers in Immunology. 9. 1246–1246. 15 indexed citations
7.
Castella, Barbara, Myriam Foglietta, Chiara Riganti, & Massimo Massaia. (2018). Vγ9Vδ2 T Cells in the Bone Marrow of Myeloma Patients: A Paradigm of Microenvironment-Induced Immune Suppression. Frontiers in Immunology. 9. 1492–1492. 26 indexed citations
8.
Salaroglio, Iris C., Elena Gazzano, Eleonora Mungo, et al.. (2018). Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer. Journal of Experimental & Clinical Cancer Research. 37(1). 286–286. 36 indexed citations
9.
Castella, Barbara, Assunta Melaccio, Myriam Foglietta, Chiara Riganti, & Massimo Massaia. (2018). Vγ9Vδ2 T Cells as Strategic Weapons to Improve the Potency of Immune Checkpoint Blockade and Immune Interventions in Human Myeloma. Frontiers in Oncology. 8. 508–508. 16 indexed citations
10.
Gazzano, Elena, Joanna Kopecka, Barbara Castella, et al.. (2018). Novel anthracyclines with enhanced immunogenic effects against drug resistant osteosarcoma cells. 1(4). 3 indexed citations
11.
Castella, Barbara, Joanna Kopecka, Giorgia Mandili, et al.. (2017). The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells. Nature Communications. 8(1). 15663–15663. 55 indexed citations
12.
Castella, Barbara, et al.. (2016). Immune Checkpoint Blockade Combinations As Promising Strategy for Cancer Immunotherapy in Multiple Myeloma Patients. Blood. 128(22). 2059–2059. 2 indexed citations
13.
Foglietta, Myriam, Barbara Castella, Sara Mariani, et al.. (2014). The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status. Haematologica. 99(10). 1605–1610. 27 indexed citations
14.
Corsetto, Paola Antonia, Ivana Campia, G. Montorfano, et al.. (2013). Omega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes composition. Molecular Cancer. 12(1). 137–137. 92 indexed citations
15.
Castella, Barbara, Candida Vitale, Marta Coscia, & Massimo Massaia. (2011). Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside. Cellular and Molecular Life Sciences. 68(14). 2419–2432. 32 indexed citations
16.
Coscia, Marta, Francesca Pantaleoni, Chiara Riganti, et al.. (2011). IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells. Leukemia. 25(5). 828–837. 56 indexed citations
17.
Castella, Barbara, Chiara Riganti, Francesca Fiore, et al.. (2011). Immune Modulation by Zoledronic Acid in Human Myeloma: An Advantageous Cross-Talk between Vγ9Vδ2 T Cells, αβ CD8+ T Cells, Regulatory T Cells, and Dendritic Cells. The Journal of Immunology. 187(4). 1578–1590. 61 indexed citations
18.
Massaia, Massimo, Sara Mariani, Francesca Pantaleoni, et al.. (2009). Direct and indirect antitumor activity of zoledronic acid. 1(8). 1 indexed citations
19.
Fiore, Francesca, Barbara Castella, Raffaello Bertieri, et al.. (2007). Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid. Blood. 110(3). 921–927. 91 indexed citations
20.
Mariani, Sara, Michela Muraro, Francesca Pantaleoni, et al.. (2005). Effector γδ T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma. Leukemia. 19(4). 664–670. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenzhi Tian Breakdown of academic impact, for papers by Grégory Ehx Breakdown of academic impact, for papers by Ninib Baryawno Breakdown of academic impact, for papers by James J. Ignatz-Hoover Breakdown of academic impact, for papers by Joel Crespo Breakdown of academic impact, for papers by Hind Medyouf Breakdown of academic impact, for papers by Leticía Huergo-Zapico Breakdown of academic impact, for papers by Bruno A. Cardoso Breakdown of academic impact, for papers by W Zhang
Rankless by CCL
2026